Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KOWA COMPANY,LTD.

Home Clinical Trial Sponsors and OrganizationsKOWA COMPANY,LTD.

KOWA COMPANY,LTD.

3-6-29, NISHIKI, NAKA-KU, Nagoya, Aichi, Japan

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

54

4 active

Approvals

17

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

30

55.6%

Phase 2

5

9.3%

Phase 4

4

7.4%

Not Applicable

2

3.7%

Phase 1

1

1.9%

Phase 2/3

1

1.9%

Trial Status Distribution

Active, not recruiting

2

3.7%

Completed

46

85.2%

Not yet recruiting

2

3.7%

Recruiting

2

3.7%

Clinical Trials

Trials sponsored by this organization (54)

A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins

Jul 2026120 participants

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance

May 202371 participants

Drug-drug interaction study of K-237 (digoxin, rosuvastatin)

Jul 202210 participants

Drug-drug interaction study of K-237 (clarithromycin, rifampicin)

May 202220 participants

Clinical pharmacology study of K-237

Oct 202112 participants

A Phase III Confirmatory Study of K-237

Oct 20211,030 participants

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Sep 2021353 participants

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Mar 2021345 participants

Page 1 of 7

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

17

Approvals

Recent Approvals

Pitavastatin Calcium Tablets

Pitavastatin Calcium Tablets

Pitavastatin Calcium Tablets

Pitavastatin Calcium Tablets

Calcium Polystyrene Sulfonate Powder

Calcium Polystyrene Sulfonate Powder

Calcium Polystyrene Sulfonate Powder

Calcium Polystyrene Sulfonate Powder

Pitavastatin Calcium Tablets

Pemafibrate Tablets

News

No news articles found

On this page

Overview
Clinical Trials54
Approvals17
News

Back to Organizations